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Cutting through complexity: the Breathing, Thinking,
Functioning clinical model is an educational tool that
facilitates chronic breathlessness management
Anna Spathis 1,2✉, Julie Burkin1, Catherine Moffat1, Rachel Tuffnell1, Stephen Barclay2, Jonathan Mant2 and Sara Booth1,2
Chronic breathlessness is a distressing symptom that is challenging to manage. The Breathing, Thinking, Functioning clinical model
is an educational tool developed to support breathlessness management. Health professionals report that the model increases
clinician and patient understanding of this complex symptom, and provides a simple and structured approach to personalised self-
management.
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Breathlessness is a debilitating symptom experienced by over a
quarter of community-dwelling older adults, and most people
with chronic respiratory conditions1,2. The global prevalence is
rising with ageing populations and increasing multi-morbidity3.
COVID-19 is further exacerbating the problem, with evidence that
a significant minority experience persistent breathlessness long
after the acute infection has resolved4.
Primary care is recognised to be particularly well placed to
support chronic breathlessness management5,6. However, health
professionals in both primary care and respiratory medicine
describe feeling ‘out of their depth’ and ‘overwhelmed’, when
attempting to control a symptom that persists despite optimal
disease management5,7. Breathlessness is, indeed, challenging to
manage. Its severity bears little relationship to that of the
underlying condition, with more than 40% of patients with mild
COPD, for example, experiencing moderate to severe breath-
lessness8. Drug treatments tend not to help. Opioids are often
prescribed, but were found to be ineffective in a recent definitive
trial9, and are associated with adverse effects and increased
mortality10–12. There is no evidence benzodiazepines improve
breathlessness13.
Non-drug measures are more effective but under-used14.
Evidence-based approaches, such as exercise, cognitive beha-
vioural therapy, activity management, mindfulness and facial
cooling, are hindered by limited patient engagement in self-
management and lack of professional expertise15–19. Pulmonary
rehabilitation is frequently inaccessible, particularly to those with
the worst symptoms, with only two out of five people referred
completing a course20. Sporadic specialist breathlessness manage-
ment programmes have emerged over the last decade. Although
effective, these have very little capacity and are mostly accessed
by patients with advanced cancer21.
Improving access to breathlessness management support is
vital. Recent consensus exercises have led to increasing calls to
prioritise the provision of education to upskill generalist health
professionals and ‘…embed core therapeutic components into
routine clinical practice’22,23. Despite this, there has been a
conspicuous lack of breathlessness management education
developed for health professionals, with the only two previous
publications describing multi-day experiential clinical skills
workshops24,25.
The Cambridge Breathlessness Intervention Service has developed
the only educational tool to support chronic breathlessness manage-
ment26. The Breathing, Thinking, Functioning (BTF) clinical model
(Fig. 1) conceptualises emotional and behavioural responses to
breathlessness, leading to vicious cycles that inadvertently worsen
the symptom or perpetuate it beyond a trigger. It explains the
disassociation between the severity of breathlessness and the
underlying condition, and provides a rationale for symptom
management: unlike drug treatments, non-drug approaches can
break a vicious cycle, turning it into a cycle of health improvement.
Each part of the model is evidence-based; for example, it is well-
established that misinterpretations of bodily sensations can lead to a
spiral of deteriorating symptoms and panic27.
International interest in the BTF model suggests high face
validity and a number of centres have incorporated the model
into their teaching28. This communication describes feedback
from health professionals who have received breathlessness
management training based on the model.
Of 209 delegates, 179 completed the pre-course questionnaire.
The three-month post-course questionnaire was sent to the 164
participants providing valid email addresses, and 109 responded.
Most participants were allied health professionals (37%) or nurses
(36%), with the remainder being doctors (10%) or of unknown
discipline (16%). Of the 85% with a known working context, more
than half (57%) worked in respiratory or primary care.
Participants were significantly more confident in managing
breathlessness three months after attending the study day
compared to baseline (73% vs. 25% rated confidence as ‘quite a
bit’ or ‘very much’; Mann–Whitney U test, p < 0.001). They also felt
more experienced in managing breathlessness (70% vs. 37% rated
the experience as ‘quite a bit’ or ‘very much’; p < 0.001) and were
using the BTF model more frequently (57% vs. 10% rated level of
use as ‘quite a bit’ or ‘very much’; p < 0.001). Most participants
considered the BTF model to be valuable in their clinical practice,
rating its usefulness as ‘very much’ (45%) or ‘quite a bit’ (36%), and
only a few ‘a little bit’ (3%) or ‘not at all’ (1%).
The majority of the free-text responses (72/118) described
useful aspects of the model. The most consistent theme (36
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comments) related to the model making sense of breathlessness
in terms of its drivers and management. The emphasis was on
patients’ understanding, with a number also alluding to profes-
sional understanding. The model was repeatedly described as
being easy to understand and use, with it making ‘sense to staff
and patients’. Patients’ increased understanding and insights, in
turn, appeared to help them self-manage breathlessness non-
pharmacologically, allowing them to ‘try to change things and
take back control’.
The second strongest topic of feedback, reflected in 16
comments, was the model’s practical value in structuring and
focusing breathlessness management. The ‘logical’ structured
approach was helpful both during symptom assessment and
management. It helped to ‘divide breathlessness up’ so it felt more
feasible to manage. The inherent structure, in turn, was
considered by many to promote individualised care, focused on
the specific needs of each person. Participants commented on the
‘flexibility of the approach’ so they could ‘tailor to the individual’,
helping them ‘identify the key problem areas and know where to
start’. Several participants alluded to it being ‘holistic’, particularly
valuing the ‘emphasis on emotional components’.
In relation to amendments, the most common response was
that no changes were needed to the model (n= 30). The
remaining comments (n= 19) fell into two themes, the main
one being participants’ requests for BTF model resources, with
‘flash cards’ or ‘pocket sized’ cards that could be used with, and
given to, patients; others suggested the development of an ‘App’
based on the model. Five participants commented on the lack of
time in short patient consultations and the need for brief
intervention, particularly in a primary care context.
The BTF clinical model was perceived to be a valuable educational
tool for health professionals managing chronic breathlessness. Three
months after attending one study day, most participants felt more
confident in their ability to manage the symptom and were finding
the model useful in their clinical practice. Qualitative data provided
further insights: the role of the model in making sense of the
symptom, and its capacity to provide an easy, structured and
personalised approach to breathlessness management. Overall, the
outcomes suggest that the fundamental benefit of the model for
health professionals comes from incising through the complexity of
this challenging symptom.
These findings are of particular pertinence to primary care,
which holds much of the burden of long-term conditions. Patients
experience symptoms, not diseases. With incurable disease and
escalating multimorbidity, symptom-focused rather than disease-
focused approaches become increasingly relevant. The BTF model
supports breathlessness self-management by facilitating
workforce training that allows staff and patients to make sense
of the symptom and enables structured, personalised intervention.
The request for App development has the potential to mitigate
the concern about time-limited patient consultations. Healthcare
digital transformation is accelerating, and electronic resources
support self-management and increase health service efficiency.
The development of a BTF App is in progress. The finding that the
model supports individually focused management reinforces its
potential role in brief intervention.
Chronic breathlessness is a global phenomenon. Breathlessness
management training and digital tools will not only improve access
to symptom control in high-income countries but can also support
the type of low-intensity, low-resource interventions urgently needed
in less wealthy nations. The COVID-pandemic is rapidly intensifying
the problem, changing the need for access to effective breath-
lessness intervention from important to imperative.
METHODS
The Cambridge Breathlessness Intervention Service delivers single study
days, underpinned by the BTF model, for any health professional wishing
to learn about chronic breathlessness management. Lectures in the
morning explain the BTF model and management of each of the three
vicious cycles; in the afternoon, participants rotated through three
experiential workshops. Participants at four of the study days (2017-19)
completed a brief questionnaire at the start of the day self-rating
experience and confidence in breathlessness management, and any
previous use of the model, using three 5-item verbal rating scales (not at
all, a little bit, somewhat, quite a bit, very much). Provision of an email
address gave implicit consent to be sent a follow-up questionnaire three
months after the study day. At this point, participants completed the same
questionnaire with an additional question about the perceived usefulness
of the model, along with free text feedback on useful aspects of, and
suggested changes to, the model. Research ethics approval was not
required as this was an education evaluation that set out to gain feedback
to improve education, rather than derive generalisable knowledge, and it
did not involve students or patients29.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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